Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 42.61B | 43.42B | 41.28B | 39.20B | 35.92B | 37.20B |
Gross Profit | 9.85B | 9.82B | 9.29B | 8.07B | 8.03B | 8.31B |
EBITDA | 3.06B | 1.96B | 4.59B | 2.06B | 1.93B | 1.91B |
Net Income | 1.48B | -120.00M | 2.70B | 931.00M | 958.00M | 727.00M |
Balance Sheet | ||||||
Total Assets | 44.21B | 40.84B | 39.95B | 38.18B | 36.23B | 38.20B |
Cash, Cash Equivalents and Short-Term Investments | 3.11B | 665.00M | 2.57B | 2.05B | 2.33B | 2.35B |
Total Debt | 8.90B | 4.56B | 4.59B | 7.27B | 6.18B | 5.77B |
Total Liabilities | 24.91B | 22.18B | 21.02B | 21.68B | 20.55B | 23.11B |
Stockholders Equity | 19.30B | 18.65B | 18.93B | 16.50B | 15.68B | 15.09B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.51B | 1.62B | -1.26B | -40.00M | -112.00M |
Operating Cash Flow | 0.00 | 1.23B | 3.06B | -694.00M | 1.74B | 1.08B |
Investing Cash Flow | 0.00 | -2.62B | 515.00M | -317.00M | -1.65B | -1.22B |
Financing Cash Flow | 0.00 | -513.00M | -3.06B | 730.00M | -113.00M | 418.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥10.42B | 9.13 | 4.38% | -4.86% | 31.22% | ||
76 Outperform | ¥56.07B | 17.76 | 1.65% | 9.88% | 62.19% | ||
74 Outperform | ¥11.09B | 7.77 | 522.89% | 7.70% | 13.39% | ||
65 Neutral | $10.75B | 15.72 | 5.20% | 1.90% | 3.09% | -27.42% | |
64 Neutral | ¥8.65B | 3.91 | 3.63% | 3.45% | 29.89% | ||
62 Neutral | ¥9.06B | 6.10 | 5.07% | 5.18% | -104.41% | ||
60 Neutral | ¥7.78B | 598.33 | 4.15% | 1.96% | -98.44% |